Entries by appshineadmin
REDCap Multicentre Registry
LHM Healthcare is participating in the REDCap Multicentre Registry as part of our commitment to Research and Development in Hyperbaric Oxygen Therapy What is the Multicenter Registry for Hyperbaric Oxygen Therapy and why do we need it? Most hyperbaric providers in the UK have experienced Individual Funding Request (IFR) denials for indications previously commissioned by […]
ECHM & EUBS Joint position statement on the use of ‘mild hyperbaric therapies’ in humans
European Committee for Hyperbaric Medicine (ECHM) & European Underwater Baromedical Society (EUBS) Joint position statement on the use of ‘mild hyperbaric therapies’ in humans Introduction Exposure of humans in hyperbaric treatment devices (hyperbaric chambers) up to 2.0 bar overpressure (equal to 20 meters depth of water) with the breathing of oxygen is known as hyperbaric […]
Undersea & Hyperbaric Medical Society Position Statement
The AMA advises against unsafe ‘mild hyperbaric oxygen therapy’ and the FDA has endorsed UHMS accreditation AMA news The American Medical Association has adopted a resolution opposing the unsafe use of so-called “mild hyperbaric oxygen therapy” in “mild hyperbaric facilities.” The policy D-270.986, adopted 26 July 2022, was initiated by the Undersea and Hyperbaric Medical […]
BHA Statement on Provision of Mild HBOT
The British Hyperbaric Association (BHA) is a charitable organisation promoting and supporting the safe and appropriate use of hyperbaric medicine in the British Isles. The BHA supports the view of the American Medical Association (AMA) and the US Food and Drug Administration (FDA) in opposing the unsafe provision of so-called “mild” hyperbaric oxygen therapy (HBOT) in “mild” facilities. A link to these important […]